Delivery Order SPE2DB20D2014-SPE2DB24FC63F
Award Date
7/31/24
Potential Completion Date
8/1/24
Potential Value
$3.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $3,938.44 order is for the delivery of EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product, to support DLA Troop Support Medical operations. The contract has a completion date of January 23, 2024. Amerisourcebergen Drug Corp, through its Corporate Office...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of EXFORGE 10-160 MG TABLET 30S. The firm fixed price contract has a ceiling value of $1,200.60 and an ultimate completion date of August 5, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a comprehensive range...
This award is a Delivery Order from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the pharmaceutical product EXFORGE 5-160 MG TABLET 30S. The award, valued at $1,592.28, has a firm fixed price and an ultimate completion date of January 30, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of EXFORGE 10-320 MG TABLET 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $23,654.73 and an ultimate completion date of September 5, 2024. AmerisourceBergen, a major pharmaceutical distributor, was awarded this contract to provide these essential medical commodities to support military treatment programs and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product, with a total ceiling value of $2,465.80. The contract is a firm fixed-price, non-set-aside award with a completion date of June 27, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,817.75 firm fixed price contract is for the delivery of EXFORGE 10-160 MG TABLET 30S, a brand name pharmaceutical product. The contract has an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp is the prime contractor on a $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The order, valued at $3,721.70, is for the supply of 4565296476 - EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product. The contract has a period of performance through July 31, 2024 and uses a Firm Fixed Price pricing type. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that AmerisourceBergen holds with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,071.78 firm fixed price contract is for the delivery of EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product, with a completion date of January 23, 2024. No set-aside designation was used. Amerisourcebergen Drug Corp, a for-profit organization, has previously received numerous federal contract awards from DLA to supply...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of EXFORGE 10-320 MG TABLET 30S, a type of medication, with a ceiling value of $3,989.54 and a performance period ending on July 2, 2025. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug...
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999. The award is for the supply of EXFORGE 5-160 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $3,365.33 and a performance period ending on April 7, 2023. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open...